Defunct Company
Total Trials
2
As Lead Sponsor
As Collaborator
0
Total Enrollment
113
NCT02112799
Safety and Efficacy Study of NVR 3-778 in Healthy Volunteers and Hepatitis B Patients
Phase: Phase 1
Role: Lead Sponsor
Start: Apr 30, 2014
Completion: May 18, 2016
NCT02401737
Dose-Ranging Study to Assess the Safety, PK and Initial Antiviral Efficacy of NVR 3-778 in Chronic HBV Patients
Start: Jan 31, 2015